廖建泉,葛均波

• 1:复旦大学附属中山医院心内科上海市心血管病研究所

摘要(Abstract)：

<正>交感神经系统参与心输出量、血压、血容量和水电解质平衡的调节,其过度兴奋被认为参与了高血压、心力衰竭、心律失常等心血管疾病的病理生理过程。肾交感神经作为交感神经的重要组成部分,通过传入神经和传出神经与全身交感神经系统相互作用、相互影响。交感神经在高血压的形成和维持过程中发挥着重要作用,原发性高血压患者肾交感神经过度激活,其末梢释放儿茶酚胺增多,引起小动脉和静脉收缩,心输出量增加;刺激肾素释放,收缩肾血管,减少肾血流,增加肾小管水钠重吸收。肾交感神经导管消融术利用导

关键词(KeyWords)： 去肾交感神经;高血压;心力衰竭;心律失常;心率

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81300096)

作者(Author): 廖建泉,葛均波

参考文献(References)：

• [1]Chobanian AV,Bakris GL,Black HR,et al.Seventh report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure.Hypertension,2003,42:1206-1252.
• [2]孙宁玲,霍勇,王继光,等.难治性高血压诊断治疗中国专家共识.中国介入心脏病学杂志,2013,21:69-74.
• [3]Kearney PM,Whelton M,Reynolds K,et al.Global burden of hypertension:analysis of worldwide data.Lancet,2005,365:217-223.
• [4]Persell SD.Prevalence of resistant hypertension in the United States,2003-2008.Hypertension,2011,57:1076-1080.
• [5]Page IH.The effect on renal efficiency of lowering arterial blood pressure in cases of essential hypertension and nephritis.J Clin Invest,1934,13:909-915.
• [6]Page IH,Heuer GJ.The effect of renal denervation on the level of arterial blood pressure and renal function in essential hypertension.J Clin Invest,1935,14:27-30.
• [7]Peet MM.Results of bilateral supradiaphragmatic splanchnieeetomy for arterial hypertension.N Engl J Med,1947,236:270-277.
• [8]Smithwick RH.Hypertensive vascular disease;results of and indications for splanchnieeetomy.J Chronic Dis,1955,1;477-496.
• [9]Krum H.Schlaich M,Whitbourn R,et al.Catheter-based renal sympathetic denervation for resistant hypertension;a multicentre safety and proof-of-principle cohort study.Lancet,2009,373:1275-1281.
• [10]Ott C,Mahfoud F,Schmid A,et al.Renal denervation in moderate treatment-resistant hypertension.J Am Coll Cardiol,2013,62:1880-1886.
• [11]Esler MD,Krum H,Sobotka PA,et al.Renal sympathetic denervation in patients with treatment-resistant hypertension(The Symplicity HTN-2 Trial):a randomised controlled trial.Lancet,2010,376:1903-1909.
• [12]Esler MD,Krum H,Schlaich M,et al.Renal sympathetic denervation for treatment of drug-resistant hypertension?one-year results from the Symplicity HTN-2 randomized,controlled trial.Circulation,2012,126:2976-2982.
• [13]Mahfoud F,Cremers B,Janker J,et al.Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.Hypertension,2012,60:419424.
• [14]Krum H,Barman N,Schlaich M,et al.Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months.Hypertension,2011,57:911-917.
• [15]Krum H,Schlaich MP,Sobotka PA,et al.Percutaneous renal denervation in patients with treatment-resistant hypertension;final 3-year report of the Symplicity HTN-1 study.Lancet,2014,383:622-629.
• [16]Bhatt DL.Kandzari DE,ONeffl WW,et al.A controlled trial of renal denervation for resistant hypertension.N Engl J Med,2014,370-1393-1401.
• [17]B?hm M,Mahfoud F,Ukena C,et al.Rationale and design of a large registry on renal denervation;the Global SYMPUCITY registry.Eurolntervention,2013,9:484-492.
• [18]Mancia G,Fagard R,Narkiewiez K,et al.2013 ESH/ESC guidelines for the management of arterial hypertension;the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC).Eur Heart J,2013,34;2159-2219.
• [19]Lobo MD.de Belder MA,Cleveland T,et al.Joint UK societies'2014 consensus statement on renal denervation for resistant hypertension.Heart,2015,101;10-16.
• [20]Ukena C,Mahfoud F,Spies A,et al.Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension.Int J Cardiol,2013,167:2846-2851.
• [21]Ukena C,Mahfoud F,Kindermann I,et al.Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension.J Am Coll Cardiol,2011,58;1176-1182.
• [22]Brandt MC,Reda S,Mahfoud F,et al.Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension.J Am Coll Cardiol,2012,60:1956-1965.
• [23]Brandt MC,Mahfoud F,Reda S,et al.Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.J Am Coll Cardiol.2012,59:901-909.
• [24]Reil JC,Custodis F,Swedberg K,et al.Heart rate reduction in cardiovascular disease and therapy.Clin Res Cardiol,2011,100:11-19.
• [25]Hasking GJ,Esler MD,Jennings GL,et al.Norepinephrine spillover to plasma in patients with congestive heart failure;evidence of increased overall and cardiorenal sympathetic nervous activity.Circulation,1986,73:615-621.
• [26]Floras JS.Sympathetic nervous system activation in human heart failure:clinical implications of an updated model.J Am Coll Cardiol,2009,54:375-385.
• [27]Gheorghiade M,Colucci WS,Swedberg K.Beta-blockers in chronic heart failure.Circulation,2003,107:1570-1575.
• [28]Masaki H,Imaizumi T,Harasawa Y,et al.Dynamic arterial baroreflex in rabbits with heart failure induced by rapid pacing.Am J Physiol,1994,267:H92-H99.
• [29]Clayton SC,Haack KK,Zucker IH.Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure.Am J Physiol Renal Physiol,2011,300:F31-F39.
• [30]Hu J,Li Y,Cheng W,et al.A comparison of the efficacy of surgical renal denervation and pharmacologic therapies in postmyocardial infarction heart failure.PLoS One,2014,9;e96996.
• [31]Davies JE,Manisty CH,Petraco R,et al.First-in-man safety evaluation of renal denervation for chronic systolic heart failure;primary outcome from REACH-Pilot study.Int J Cardiol,2013,162:189-192.
• [32]Verloop WL.Beeftink MM,Nap A,et al.Renal denervation in heart failure with normal left ventricular ejection fraction.Rationale and design of the DIASTOLE(Denervation of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction)trial.Eur J Heart Fail,2013,15:1429-1437.
• [33]Sharifov OF,Fedorov W,Beloshapko GG,et al.Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs.J Am Coll Cardiol,2004,43:483-490.
• [34]Pokushalov E,Romanov A,Corbucci G,et al.A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension.J Am Coll Cardiol,2012,60:1163-1170.
• [35]Schwartz PJ,Priori SG,Cerrone M,et al.Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.Circulation,2004,109:1826-1833.
• [36]Wilde AA.Bhuiyan ZA,Crotti L,et al.Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.N Engl J Med,2008,358:2024-2029.
• [37]Ukena C,Bauer A,Mahfoud F,et al.Renal sympathetic denervation for treatment of electrical storm;first-in-man experience.Clin Res Cardiol,2012,101:63-67.
• [38]Ukena C,Mahfoud F,Linz D,et al.Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias.Eurolntervention,2013,9 Suppl R:R110-R116.